IL1B and Cognitive impairment: When comparing studies using chemotherapy in healthy versus tumor-bearing animal models, both groups exhibited a consistent pattern of cognitive impairment accompanied by increased levels of pro-inflammatory cytokines, particularly IL-1β, IL-6, and TNF-α.